Outset Medical, Inc. (OM)
$4.01-0.99%Close
BUYRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $74M
- Beta
- 1.90
- P/E (TTM)
- -1.01
- Short % float
- 4.55%
- Days to cover
- 5.9
- SI change
- -10.9%
- 1W
- -2.20%
- 1M
- +24.92%
- vs SPY 1W
- -2.62%
- vs SPY 1M
- +22.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 11
- GROWTH
- 29
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-37.4%
REV YoY-
ROE-62.3%
EPS YoY-
ROA-30.6%
GROSS42
OP-56
NET-63
[VALUATION]
P/E TTM-1.01
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B0.80
P/FCF-
EV/EBITDA-2.60
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E108.42
ALTMAN Z-
CURR RATIO5.19
ND/EBITDA-
BETA1.90
Company news
FAQ
- What is LOPJLB’s current signal on OM?
- LOPJLB’s latest quantitative signal on Outset Medical, Inc. (OM) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is OM in?
- Outset Medical, Inc. (OM) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Outset Medical, Inc. (OM) do?
- Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advance…